These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 18166243

  • 1. Increase of therapeutic effects by treating melanoma with targeted combinations of c-myc antisense and doxorubicin.
    Pastorino F, Mumbengegwi DR, Ribatti D, Ponzoni M, Allen TM.
    J Control Release; 2008 Feb 18; 126(1):85-94. PubMed ID: 18166243
    [Abstract] [Full Text] [Related]

  • 2. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
    Pastorino F, Brignole C, Marimpietri D, Pagnan G, Morando A, Ribatti D, Semple SC, Gambini C, Allen TM, Ponzoni M.
    Clin Cancer Res; 2003 Oct 01; 9(12):4595-605. PubMed ID: 14555535
    [Abstract] [Full Text] [Related]

  • 3. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
    Pastorino F, Brignole C, Marimpietri D, Di Paolo D, Zancolli M, Pagnan G, Ponzoni M.
    Ann N Y Acad Sci; 2004 Dec 01; 1028():90-103. PubMed ID: 15650235
    [Abstract] [Full Text] [Related]

  • 4. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW, Allen TM.
    J Control Release; 2008 Feb 18; 126(1):50-8. PubMed ID: 18068849
    [Abstract] [Full Text] [Related]

  • 5. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G, D'Agnano I, Leonetti C, Perini R, Bucci B, Zon G, Calabretta B, Zupi G.
    Cancer Res; 1998 Jan 15; 58(2):283-9. PubMed ID: 9443406
    [Abstract] [Full Text] [Related]

  • 6. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
    Pastorino F, Brignole C, Marimpietri D, Sapra P, Moase EH, Allen TM, Ponzoni M.
    Cancer Res; 2003 Jan 01; 63(1):86-92. PubMed ID: 12517782
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma.
    Lopes de Menezes DE, Pilarski LM, Allen TM.
    Cancer Res; 1998 Aug 01; 58(15):3320-30. PubMed ID: 9699662
    [Abstract] [Full Text] [Related]

  • 8. Combined targeting of perivascular and endothelial tumor cells enhances anti-tumor efficacy of liposomal chemotherapy in neuroblastoma.
    Loi M, Marchiò S, Becherini P, Di Paolo D, Soster M, Curnis F, Brignole C, Pagnan G, Perri P, Caffa I, Longhi R, Nico B, Bussolino F, Gambini C, Ribatti D, Cilli M, Arap W, Pasqualini R, Allen TM, Corti A, Ponzoni M, Pastorino F.
    J Control Release; 2010 Jul 01; 145(1):66-73. PubMed ID: 20346382
    [Abstract] [Full Text] [Related]

  • 9. Tumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomes.
    Hatakeyama H, Akita H, Ishida E, Hashimoto K, Kobayashi H, Aoki T, Yasuda J, Obata K, Kikuchi H, Ishida T, Kiwada H, Harashima H.
    Int J Pharm; 2007 Sep 05; 342(1-2):194-200. PubMed ID: 17583453
    [Abstract] [Full Text] [Related]

  • 10. Increase of cisplatin sensitivity by c-myc antisense oligodeoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin.
    Leonetti C, Biroccio A, Candiloro A, Citro G, Fornari C, Mottolese M, Del Bufalo D, Zupi G.
    Clin Cancer Res; 1999 Sep 05; 5(9):2588-95. PubMed ID: 10499637
    [Abstract] [Full Text] [Related]

  • 11. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy.
    Pastorino F, Brignole C, Marimpietri D, Cilli M, Gambini C, Ribatti D, Longhi R, Allen TM, Corti A, Ponzoni M.
    Cancer Res; 2003 Nov 01; 63(21):7400-9. PubMed ID: 14612539
    [Abstract] [Full Text] [Related]

  • 12. Experimental anticancer therapy with vascular-disruptive peptide and liposome-entrapped chemotherapeutic agent.
    Sochanik A, Mitrus I, Smolarczyk R, Cichoń T, Snietura M, Czaja M, Szala S.
    Arch Immunol Ther Exp (Warsz); 2010 Jun 01; 58(3):235-45. PubMed ID: 20383751
    [Abstract] [Full Text] [Related]

  • 13. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
    Brignole C, Pastorino F, Marimpietri D, Pagnan G, Pistorio A, Allen TM, Pistoia V, Ponzoni M.
    J Natl Cancer Inst; 2004 Aug 04; 96(15):1171-80. PubMed ID: 15292389
    [Abstract] [Full Text] [Related]

  • 14. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM, Mumbengegwi DR, Charrois GJ.
    Clin Cancer Res; 2005 May 01; 11(9):3567-73. PubMed ID: 15867261
    [Abstract] [Full Text] [Related]

  • 15. A metronomic schedule of cyclophosphamide combined with PEGylated liposomal doxorubicin has a highly antitumor effect in an experimental pulmonary metastatic mouse model.
    Shiraga E, Barichello JM, Ishida T, Kiwada H.
    Int J Pharm; 2008 Apr 02; 353(1-2):65-73. PubMed ID: 18155369
    [Abstract] [Full Text] [Related]

  • 16. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects.
    Pagnan G, Stuart DD, Pastorino F, Raffaghello L, Montaldo PG, Allen TM, Calabretta B, Ponzoni M.
    J Natl Cancer Inst; 2000 Feb 02; 92(3):253-61. PubMed ID: 10655443
    [Abstract] [Full Text] [Related]

  • 17. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G, Scarsella M, Semple SC, Mottolese M, Natali PG, Leonetti C.
    Clin Cancer Res; 2005 Mar 01; 11(5):1990-8. PubMed ID: 15756025
    [Abstract] [Full Text] [Related]

  • 18. In vivo distribution of c-myc antisense oligodeoxynucleotides local delivered by gelatin-coated platinum-iridium stents in rabbits and its effect on apoptosis.
    Zhang XX, Cui CC, Xu XG, Hu XS, Fang WH, Kuang BJ.
    Chin Med J (Engl); 2004 Feb 01; 117(2):258-63. PubMed ID: 14975213
    [Abstract] [Full Text] [Related]

  • 19. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J, Lee A, Lu Y, Lee RJ.
    Int J Pharm; 2007 Jun 07; 337(1-2):329-35. PubMed ID: 17275230
    [Abstract] [Full Text] [Related]

  • 20. Effect of transferrin receptor-targeted liposomal doxorubicin in P-glycoprotein-mediated drug resistant tumor cells.
    Kobayashi T, Ishida T, Okada Y, Ise S, Harashima H, Kiwada H.
    Int J Pharm; 2007 Feb 01; 329(1-2):94-102. PubMed ID: 16997518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.